LON:BVXP Bioventix (BVXP) Share Price, News & Analysis GBX 1,811 -33.50 (-1.82%) As of 05:24 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider TradesNews and Trends About Bioventix Stock (LON:BVXP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bioventix alerts:Sign Up Key Stats Today's Range 1,800▼ 1,85050-Day Range 1,471.11▼ 1,844.5052-Week Range 1,300▼ 2,700Volume8,276 shsAverage Volume10,908 shsMarket Capitalization£94.62 millionP/E Ratio12.89Dividend Yield8.57%Price TargetN/AConsensus RatingN/A Company Overview Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom. Read More Receive BVXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BVXP Stock News HeadlinesDown 43% with a 9% dividend yield – should I buy this stock?June 7, 2026 | uk.finance.yahoo.comPeter Harrison Spends UK£39k On Bioventix StockApril 12, 2026 | finance.yahoo.comTomorrow, Wall Street goes home for two daysTomorrow at 4 PM Eastern, Wall Street closes for the weekend. Fund managers and billion-dollar accounts leave, but news doesn't. Contract announcements, FDA approvals, buyout rumors can hit smaller stocks all weekend with almost nobody watching until Monday. Millionaire trader Tim Sykes built a strategy around this gap, and he calls it the Weekend Gap.October 12 at 1:00 AM | Tim Sykes (Ad)Are Bioventix PLC's (LON:BVXP) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?February 9, 2026 | finance.yahoo.comDown 43%, should I unlock this 8.3% yield for my stocks and shares ISA?January 24, 2026 | msn.comWith 68% ownership of the shares, Bioventix PLC (LON:BVXP) is heavily dominated by institutional ownersJanuary 6, 2026 | finance.yahoo.comPleasing Signs As A Number Of Insiders Buy Bioventix StockDecember 15, 2025 | finance.yahoo.comBioventix Share Chat (BVXP)December 10, 2025 | lse.co.ukSee More Headlines BVXP Stock Analysis - Frequently Asked Questions How have BVXP shares performed this year? Bioventix's stock was trading at GBX 1,905 at the start of the year. Since then, BVXP stock has decreased by 3.2% and is now trading at GBX 1,844.50. How were Bioventix's earnings last quarter? Bioventix PLC (LON:BVXP) posted its quarterly earnings data on Monday, March, 30th. The biotechnology company reported $69.38 earnings per share (EPS) for the quarter. The biotechnology company earned $6.16 billion during the quarter. Bioventix had a net margin of 59.30% and a trailing twelve-month return on equity of 65.83%. How do I buy shares of Bioventix? Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Bioventix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON). Company Calendar Last Earnings3/30/2026Today10/12/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolLON:BVXP CIKN/A Webwww.bioventix.com Phone+44-1252-728001FaxN/AEmployees12Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 140.52 Trailing P/E Ratio12.89 Forward P/E Ratio10.89 P/E GrowthN/ANet Income£8.12 million Net Margins59.30% Pretax MarginN/A Return on Equity65.83% Return on Assets54.07% Debt Debt-to-Equity RatioN/A Current Ratio6.12 Quick Ratio5.50 Sales & Book Value Annual Sales£12.54 million Price / Sales7.54 Cash FlowGBX 58.63 per share Price / Cash Flow30.89 Book ValueGBX 229.94 per share Price / Book7.88Miscellaneous Outstanding Shares5,225,000Free FloatN/AMarket Cap£94.62 million OptionableNot Optionable Beta0.56 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (LON:BVXP) was last updated on 10/12/2026 by MarketBeat.com Staff. From Our PartnersUrgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20thMarc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a s...Chaikin Analytics | SponsoredFree Ticker: Anthropic's silent partner could soar after record $2 trillion IPOAnthropic's IPO prospectus just leaked, revealing 261 pages tied to a record $2 trillion valuation. Beyond ...Monument Traders Alliance | SponsoredTomorrow, Wall Street goes home for two daysTomorrow at 4 PM Eastern, Wall Street closes for the weekend. Fund managers and billion-dollar accounts leave,...Tim Sykes | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredI've seen this movie before (last time: 17,556%)My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...Crypto 101 Media | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BVXP Stock Alerts